Cyclodextrin (CDs)
Cyclodextrin (CDs) is a kind of cylco-Oligosaccaride. It is also the most steady and popular molecule microcapsule materials in recent time, It is natural and made
from natural starch. The conformation of the glucose units
in the cyclodextrin places the hydrophilic hydroxyl
groups at the top and bottom of the three dimensional ring and the hydrophobic glycosidic groups on the interior.So the outer side of bucket keeps strong hydrophile characteristics, the inner side of bucket keeps hydrophobic characteristics.
Just because of the unique bucket’s hydrophilic characteristics of outter side and hydrophobe charaacteristics of inner side, it can entrap many kinds of
guest moleculesin their internal, particularly to
entrap oil form substance and form inclusion complexes. If the guest substance included by cyclodextrin to form inclusion complexes, the stability and solubility increase obviously , and volatility reduced a lot. Depending on it’s unique characteristc, CD is widely applied in the fields of
pharmaceuticals industry, food industry, cosmetics industry and household chemicals,light industry,agricultures etc.
I Hydroxypropyl-Betacyclodextrin (HP-BCD)
Hydroxypropyl beta-cyclodextrin (HP-BCD) is produced from beta-cyclodextrin (BCD) by addition of propylene oxide to some
of the hydroxyl groups of BCD. This modification results in greater solubility
of HP-BCD and its complexes compared to BCD. Therefore, HPBCD is used in
applications where the solubility of BCD is not sufficiently high and in
applications where faster dissolution rates are needed. Other benefits obtained
by complexation with the basic BCD, such as
protection against chemical degradation and volatilisation are retained by the HP-BCD. HPBCD, in dry form or in solution, is applied in a
wide variety of compounds in diverse applications such as pharmaceutical,
personal care/cosmetics, diagnostics, chemical processing and many more.
Description
Hydroxypropyl beta-cyclodextrin (HP-BCD) (CAS 94035-02-6) is a partially substituted poly (hydroxypropyl)
ether of beta cyclodextrin (BCD). The empirical
formula is:
(C42H70-nO35)
(C3H7O)n
It contains not less than 10.0%
and not more than 45.0% hydroxypropoxy (-OCH2CHOHCH3)
groups. The structure is shown below where R represents either hydrogen or a hydroxypropoxy group.
where R= CH2CHOHCH3)
or H
The basic closed circular
structure of BCD is maintained in HP-BCD. The glycosidic oxygen forming the bond between the adjacent glucose monomers and the hydrogen
atoms lining the cavity of the cyclodextrin impart an
electron density and hydrophobic character to the cavity. Organic compounds
interact with the walls of the cavity to form inclusion complexes. The hydroxyl
groups and the hydroxypropyl groups are on the
exterior of the molecule and interact with water to provide the increased
aqueous solubility of the HP-BCD and the complexes made with the HP-BCD.
Degree of substitution
The hydroxypropyl groups are randomly substituted onto the hydroxyl groups of the cyclodextrin and the amount of substitution is reported as
average Degree of Substitution (DS) or number of hydroxypropyl groups per cyclodextrin and is the preferred manner
of describing the substitution. An alternative measurement is Molar
Substitution (MS) or the average number of substitutions per anhydro glucose unit in the ring of the cylcodextrin.
Molar substitution is used with polymers whose molecular weight is not
determined or contains a mixture of polymers of different degrees of polymerisation.
Substitution occurs randomly with
respect to which hydroxyl groups and which glucose units are modified. There is
a distribution around the average degree of substitution of the number of hydroxypropyl groups per cyclodextrin,
with some molecules having more than the average and some less than the average
degree of substitution. The result is a mixture of many molecular species with
respect to the number and location of substitutions around the ring of the cyclodextrin. The reaction to produce HP-BCD is highly
controllable and repeatable, so the product is consistent from batch to batch.
Substitution can have an effect
on the binding of guests to the HP-BCD. At low degrees of substitution, binding
is very similar to that of the unmodified beta-cyclodextrin.
Increasing substitution can lead to weaker binding of the guest due to steric hindrance. The effect is dependent upon the
particular guest. It is even possible to obtain increased binding as a result
of an increase in surface area to which the guest can bind. With most guests,
these differences in binding at different degrees of substitution are small, if
detectable at all.
Applications
Hydroxypropyl Beta Cyclodextrin (HP-BCD) Properties:
HP-BCD retains the
properties of β-CD on the whole. But HP-BCD still has some different
properties, for example:
1、HP-BCD is in normal temperature water-soluble is very
high, about over 50%, so it can't crystalize in
alcohol.
2、The selectivity of held matter of HP-BCD is different
from β-CD, it probably is changed for some matter holding molecular proportion.
3、HP-BCD neither is resolved and metabolized nor
accumulate on the whole, HP-BCD is taked orally that
the majority excrete to outside the body with the excretion, the majority will
be excrete to outside the body with the urine if the medicine is not absorbed
by bowels.
4、HP-BCD can promote held matter to release quickly in
organism.
5、The suerface activation and haemolysis activation of HP-BCD are low than B-CD or other derivative,the usage is more safety.
HP-BCD contains
above-mentioned pioperties, therefore it suffers the extensive concern in the medicine
field more and more. In order to strengthen people understanding the
application aspect of HP-BCD, and below illustrate with example:
1、In the aspect of increasing water-soluble of insoluble
medicine. For example, Dihydroartemisinin and Artemether are all insoluble in water. After holding by HP it's solubility can reach to the standard of Injection
power. The solubility of Digoxinum which in the 50% HP solution increases from 0.07mg/ml to 68mg/ml.
2、In the aspect of increasing medicinal stability. For
example, after estradiol is hold by HP-BCD, taking it in room
temperature, its degradable half-life extends from 1.2 years to 4 years.
3、In the aspect of dropping medicinal harmful side
effect. For example, We can use HP-BCD to make the
injection, and then make intramuscular injection, this way can make the
absorption of living thing for medicine to obviously increase, and alleviate
the harm for stomach and intestines or muscle.
4、In strengthening medicine bioavailability ratio respect.
5、In the safety of HP-BCD respect. According to systermatic subacute and chronic
toxicity research certificate, HP-BCD neither leads to disease nor leads to
death for samll mouse. After the rabbit is
intravenous injection, HP-BCD is run off from the blood at once, and it will be
excrete to outside the body with the urine, continuous injection hasn't bad
symptoms too. For mouse and monkeys intravenous inject 200mg/kg of HP-BCD, it
will hasn't clinical influence. The dosage of oral taken or intravenous
injection HP-BCD is 15g/kg or 10g/kg respectively, it doesn't lead to death for
monkeys, too. Human beings' clinical research makes known to oral taken,
intravenous infusion, intravenous injection, nasal cavity, under the tongue and
eyes for HP-BCD, doesn't show bad reaction and irritant for eyes and muscle.
Thus it can be proved that HP-BCD is very safety for living thing.
It will be safe
absolutely if accords to following method to use HP-BCD:
The applicative
method and dosage of HP-BCD for human body:
1、Intravenous infusion Total weight of application: 30g
Method of application: 5% continuous uses 4 days
2、Intravenous injection Total weight of application: 3g
Dosage: 150mg/kg Method of application: 5% continuous uses 4 days
3、Oral taken (percent) Total weight of application:
0.2g/kg Dosage: 0.2mg/kg Method of application: pill
4、Nasal cavity Total weight of application: 600mg/day
Dosage: 40mg/day Method of application: 10% aqueous solution
5、Oral cavity under the tough Total weight of
application: 120mg/kg Dosage: 120mg/kg Method of application: pill
6、Skin Method of application: 45% aqueous solution
HP-BCD hemolysis actived and surface actived is low, it isn't irritant for skin and muscle, even
if the consistency of HP-BCD get 100mg/ml, to inject for muscle,it is irritant, too. In these aspect, HP-BCD is better
than other solutizers.
To sum up HP-BCD
is the best medicine carrier certainly in the present.
Applications
The application directions of Hydroxypropyl-beta-cyclodextrin:
Hydroxypropyl-beta-cycoldextrin is abbreviated to HP-BCD or HPB,it is hydrogen atom which is
in the remains of glucose in β-CD 2-, 3- and 6-hydroxl, is replaced hydroxypropyl-oxygen by HP.
HP-BCD, as β-CD,
to many other chemical compounds, not only has fine holding action, which
develop dissolubility of held matter, also has the advantages of high
water-soluble, improvement the release speed of held medicine in the organism
and high biological stability . HP-BCD not only
getting to safety properties is wide-ranging but also is a medicine subsidiary
material what it hasn't harmful side effects
HP-BCD Caution:
1、HP-BCD is easy dissolved in water oneself. In room
temperature, solubility>50g/100ml, even to get over 80g/100ml. When
its consistency is <40%, it flows very well, not sticking.
After medicine and HP-BCD form compound matter, medical consistency of raise
and HP-BCD of consistency of raise are linear relationship.
2、When HP-BCD or HP-BCD of medical compound matter was
made aqueous solution, produced a volume expansion obviously, their volume
expansion are about 1ml/g below low consistency (<50% w/v).
When the consistency >20% (w/v), the volume expansion is about
0.7ml/g.
3、HP-BCD is soluble in methanol and ethanol, this
situation for raising medical holding provided extensive chance. Usually HP-BCD
and medical holding is in a ratio (w/w) of 10-20 to 1 (their ratio can enlarge
30-40 to 1 under some situation), using above-mentioned the technology of
raising solubility, HP-BCD of dosage reduced 7-8 to 1 obviously (or 20-30 to
1).
4、HP-BCD aqueous solution is steady for high pressure
sterilization temperature and pressure of influence, and 45% (w/v) of HP-BCD
aqueous solution can be filtrated by 0.2μ of filter to kill germs below low
temperature.
5、HP-BCD is idea medicine that it conquers to
universally existent questions in biology products.
In the aspect of
HP-BCD increasing medical stability, raising the medicine (can't soluble in
water) of solubility, reducing medical irritability for people, raising medical
biology utilization ratio as so on, it will bring about important effect. So
HP-BCD has a vast range of prospects of development.
The commonly used method for HP-BCD
holding medicine (or other matter):
1、Ingredient
a) If the holding
matter is water-soluble matter, you will can according fixed proportion to be soluble in water.
b) If the holding
matter isn't water-soluble matter, you will can solubilize holding matter in ethanol、methanol or soluble solvent for holding
matter. In addition, when HP-BCD solubilizes in water
or alcohol, according to fixed proportion to solubilize each other or mix.
2、Promoting the method of holding reaction (the
following handling method, you'd better adjust the temperature higher, it's
gradually getting low temperature in the course of the handling.)
a) Taking
above-mentioned mixed solution, to stir high speed in room temperature or low temperature.
b) Given
above-mentioned condition to treat by ultrasonic wave.
c) Given above-mentioned to grind by milling
.
d) Using
above-mentioned high pressure (or low pressure) starch.
3、Holding compound matter of drying
The specimens
which are after holding and handling can adopt, reduce pressure to dry beside
then shatter.
4、Holding compound matter of examination
You can adopt
fluorescent light spectrum law to test holding matter how to form normal
number, in addition, you can also adopt NMR law to analyze HP-BCD for certain
matter of holding information.
5、Holding matter of releasing and picking up.
a) Under the
normal situation, holding compound matter is basic steady. In water solution,
it usual isn't released by insoluble holding matter in water. But there are
some holding matter are fit for HP-α-CD or HP-γ-CD, their stable constants are
lower after they and HP-BCD formal holding compound matter, so if they are
taken in aqueous solution for long time, holding matter is released of its own
accord from HP-BCD, too, and it will form some sediment in water.
b) When holding
compound matter is in water solution, it makes holding water-soluble matter
enlarge released speed and released measure with the temperature of going up,
under the suitable condition making released matter consistency and holding
matter consistency by HP-BCD get to balance.
c) Holding
compound matter can be extract again and again by some organic solvent (it will
be best solvent which is HP-BCD can't be dissolve.) the method can make holding
matter to be extract.
All
kind of above-mentioned holding principle, holding compound matter of
character, just for HP-BCD reference. You can choose different handling methods to different
quality of matter. Even if the same handling method, they still get different
holding effect possibly for handling temperature, solution consistency, long or
short handling times, handling intensity.
We hope that the
users can according to holding matter of quality to choose suit handling method
and holding condition, so that it make to get the best holding effect. If you
need to help for usage technology, our company of technology department will
assist to solve with all our strength.
II Alpha+Beta+Gama Mixed cyclodextrin (K50)
The
usage of mixed cylcodextrin is similar to other cyclodextrin, it and mainly can be applicated into food industry, and solves the problem of requiring part of alpha-cyclodextrin. and keeps better
water solubility problem of betacylcodextrin.
III Betacyclodextrin ( BCD), or Betadex
Beta-cyclodextrin is a non-reducing cyclic saccharide consisting of seven α-1,4-linked D-glucopyranosyl units. Theproduct is manufactured by the action of
the enzyme cycloglycosyltransferase (CGTase) obtained from Bacillus circulans, |